is semaglutide dangerous
Patients who move from semaglutide to tirzepatide typically see an extra 10-15% body-weight loss, prompting the switch. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Efficacy and Side-Effect Drivers I first noticed the
is semaglutide dangerous
Patients often switch from semaglutide to tirzepatide because the latter can deliver greater weight loss and a different side-effect profile. Both drugs belong to the GLP-1 receptor agonist family, but tirzepatide also activates GIP receptors, which may enhance appetite control. Understanding the nuances helps clinicians and patients decide which therapy
is semaglutide dangerous
People switch from semaglutide to tirzepatide primarily because tirzepatide often delivers greater weight loss with a tolerable side-effect profile. In clinical practice I’ve seen the transition reduce gastrointestinal complaints while preserving glucose control, making it an attractive option for those who hit a plateau on semaglutide. Medical Disclaimer: This